Publication:
Combined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Report

dc.contributor.authorAsil, TALİP
dc.contributor.authorIr, Nasif
dc.contributor.authorKaraduman, Fatih
dc.contributor.authorCagli, Bekir
dc.contributor.authorTuncel, Sedat
dc.contributor.institutionauthorASİL, TALIP
dc.date.accessioned2020-10-29T22:37:39Z
dc.date.available2020-10-29T22:37:39Z
dc.date.issued2012-03-01T00:00:00Z
dc.description.abstractCapsular warning syndrome is characterized by recurrent transient ischemic attacks and is caused by microthrombosis or hypoperfusion of small-sized vessels. The pathophysiological basis of this syndrome is not well understood and currently a consensus has not been reached on its optimal treatment. In this study, we present 2 cases with favorable clinical outcomes after combined antithrombotic treatment with loading doses of clopidogrel and aspirin.
dc.identifier.citationAsil T., Ir N., Karaduman F., Cagli B., Tuncel S., -Combined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Report-, NEUROLOGIST, cilt.18, ss.68-69, 2012
dc.identifier.doi10.1097/nrl.0b013e318247b9a5
dc.identifier.pubmed22367831
dc.identifier.scopus84858110611
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26660
dc.identifier.wosWOS:000300908200003
dc.titleCombined Antithrombotic Treatment With Aspirin and Clopidogrel for Patients With Capsular Warning Syndrome A Case Report
dc.typeArticle
dspace.entity.typePublication
local.avesis.idb801e3c6-56d8-4d89-a069-1abfc4399948
local.publication.isinternational1
relation.isAuthorOfPublicationd6d2b335-cf30-4de8-b2c6-9d158f661759
relation.isAuthorOfPublication.latestForDiscoveryd6d2b335-cf30-4de8-b2c6-9d158f661759
Files